Natural Product Sciences

The Korean Society of Pharmacognosy (한국생약학회)
권호 표지

Antithrombotic Activities of Chungpesagantang, Sunghyangjunggisan and Yangkyuksanwhatang

  • Published : 2002.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

The possibility of Chungpesagantang, Sunghyangjunggisan and Yangkyuksanwhatang, which have been recommended for stroke patients with constipation in traditional Korean clinics, was evaluated as a novel antithrombotic agent. Chungpesagantang potently inhibited ADP- and collagen-induced rat platelet aggregation in vitro, but Sunghyangjunggisan and Yangkyuksanwhatang did not inhibit it. However, all tested herbal formulae inhibited in vivo ADP- and collagen-induced rat platelet aggregation and extended the bleeding time of mice tails. All these herbal formulae did not affect certain plasma clotting times such as APTT, PT and TT. Among these herbal formulae, Chungpesagantang showed significant protection against death due to pulmonary thrombosis in mice. Based on these findings, these herbal formulae should prevent thrombosis and cardiovascular diseases such as myocardial infraction stroke, and arteriosclerosis.

Keywords

References

  1. Choo, M. K., Park, E. K., Yoon, H. K. and Kim D.-H. Andthrombotic and Antiallergic Activities of Daidzein, a Metabolite of Puerarin and Daidzin Produced by Human Intestinal Microflora. Biol. Pharm. Bull. In press (2002)
  2. Bom, G. V. R., and Cross, M. J., The aggreagation of blood platelet. J. Physiol., 168, 178-195 (1963) https://doi.org/10.1113/jphysiol.1963.sp007185
  3. Dinerman, J. L., and Mehta, J. L., Endothelial, Platelet and leukocyte interactions in ischemic heart disease: insights into potential mechanisms and their clinical relevance. J. Am. Coll. CardioI., 16, 207-222 (1990) https://doi.org/10.1016/0735-1097(90)90481-4
  4. Di Minno, G., and Silver, M., Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol., J. Pharmacol. Exp. Ther., 225, 57-60 (1983)
  5. Hara, T., Yokoyama, A., Ishihara, H., Yokoyama, Y., Nagahara, T., and Iwanoto, M., DX-9065a, a new synthetic, potent anticoagulant and selective inhibitor for factor Xa. Thromb. Haemost., 71, 314-319(1994)
  6. Homstra, G., Christ-Hazelhof, E., Haddeman, E., Ten, H. F., and Nussteren, D. H., Fish oil feeding lowers thromboxane- and prostacyclin production by rat platelets and aorta and does not result in the formation of prostaglandin I_3. Prostaglandins, 21, 727-738 (1981) https://doi.org/10.1016/0090-6980(81)90230-6
  7. Kim, D.-H., Yu, K.-U., Bae, E.-A., and Han, M.J., Metabolism of puerarin and daidzin by human intestinal bacteria and their relation to in vitro cytotoxicity. 21, 628-630 (1998)
  8. Kimura, Y., Tani, T., Kanbe, T., and Watanabe, K., Effect of cilostazol on platelet aggregation and experimental thrombosis., Arzneim., Forsch. Drug Res., 35, 1144-49 (1985)
  9. MacMahon, S., and Sharpe, N., Long-term antiplatelet therapy for the prevention of vascular disease. Med. J. Aust., 154, 477-80 (1991)
  10. Mustard, J. F., Platelets, thrombosis and drugs. Drugs 9, 19-76 (1975) https://doi.org/10.2165/00003495-197509010-00003
  11. Mustard, J. F., Packham, M.A., and Kinlough-Rathbone, R. L., Platelets, blood flow, and the vessel wall. Circulation 81, 124-7 (1990)
  12. Packham, M. A., Role of platelets in thrombosis and hemostasis. Can. J. PhysioI Pharmacol., 72, 278-84 (1994) https://doi.org/10.1139/y94-043
  13. Stein, B., and Fuster, V., Role of platelet inhibitor therapy in myocardial infarction. Cardiovasc. Drugs Ther., 3, 797-813 (1989) https://doi.org/10.1007/BF01869563
  14. Teng, C. M., and Ko, F. N., Comparison of the platelet aggregation induced by three thrombin-like enzymes of snake venoms and thrombin. Thromb. Haemost., 59, 304-309 (1988)